Predicting heart disease severity with simple blood tests
Part of Heart & circulation clinical trials.
This study looks at two simple blood test measures to see if they can predict how severe coronary artery disease is in people having a heart attack. It aims to find better ways to assess risk right when you arrive at the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a heart attack or a related emergency (acute coronary syndrome).
- You are going to have an emergency procedure (primary PCI) to open blocked arteries.
- You are able to understand and agree to participate in the study.
- You have not been taking cholesterol-lowering statin medication before this event.
- You do not have severe kidney disease (with a specific low kidney function).
- Your medical records are complete and you can be followed up with.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines blood samples from people with different types of coronary artery disease to understand the condition better. It may help doctors learn how to treat heart problems in the future.
This study is checking if two simple, inexpensive blood tests (NLR and CRP) can help predict how well someone with a certain type of heart attack (STEMI) will do. It aims to find a cheaper way to guide treatment and monitor recovery.
This study is checking if a simple blood test (hs-CRP to albumin ratio) can help predict outcomes in people who have had a heart attack or unstable angina but are not getting an immediate balloon/stent procedure. It aims to use inflammation markers to guide better care.
This study looks at blood markers (inflammation and heart damage indicators) in patients who have just had a heart attack or severe chest pain. Researchers want to understand how these markers relate to heart function to improve patient care.
This study tests whether an artificial intelligence tool can accurately predict a heart attack (acute coronary syndrome) by looking at the properties of your white blood cells. If successful, it could help doctors diagnose heart attacks faster from a simple blood sample.
This trial looks at two blood test results in people who have had a heart attack or unstable angina. It aims to see if these markers can help doctors understand the severity of the condition.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.